Study of Adalimumab (HUMIRA®) in Patients With Moderate to Severe Psoriasis (PS) in Spain (PROMISE)

NCT01076192 · clinicaltrials.gov ↗

COMPLETED

Status

547

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate-to-severe Chronic Plaque Psoriasis

Sponsor

AbbVie (prior sponsor, Abbott)

Collaborators

[object Object]